Gemifloxacin - PDFSEARCH.IO - Document Search Engine

Gemifloxacin
Results: 17

#	Item
1	Fluoroquinolones and risk of QT-interval prolongation Final SmPC and PL wording agreed by the PhVWP in April 2012 Doc.Ref.: CMDh/PhVWP[removed]Rev.1 April[removed]Gemifloxacin and moxifloxacin Add to Reading List Source URL: www.hma.eu Language: English - Date: 2012-04-27 07:12:17 Cardiac dysrhythmia Cyclopropanes Organofluorides Cardiac electrophysiology Moxifloxacin QT interval Long QT syndrome Torsades de pointes Ventricular tachycardia Chemistry Organic chemistry Piperazines
2	PRE-DECISIONAL AGENCY INFORMATION Add to Reading List Source URL: www.fda.gov Language: English - Date: 2006-09-11 08:16:53 Clinical research Pharmaceutical industry Pharmacology Piperazines Cyclopropanes Food and Drug Administration Clinical trial Adverse event Gemifloxacin Chemistry Organic chemistry Pharmaceutical sciences
3	Safety Review J. Paul Waymack, M.D., Sc.D. CC75 Considering Side Effects Add to Reading List Source URL: www.fda.gov Language: English - Date: 2006-11-13 13:21:30 Cyclopropanes Moxifloxacin Gemifloxacin Pefloxacin Quinolone Levofloxacin Ciprofloxacin Grepafloxacin Adverse event Organic chemistry Chemistry Piperazines
4	Benefit/Risk & Conclusion Gary Patou, MD CC98 Gemifloxacin Add to Reading List Source URL: www.fda.gov Language: English - Date: 2006-11-13 13:21:30 Piperazines Antibiotics Gemifloxacin Oximes Pyrrolidines Moxifloxacin Quinolone Levofloxacin Antibiotic resistance Organic chemistry Chemistry Cyclopropanes
5	Microsoft Word - BRIEFINGDOCGEMI ABS Aug[removed]TC-SB Final.doc Add to Reading List Source URL: www.fda.gov Language: English - Date: 2006-09-11 08:16:48 Piperazines Cyclopropanes Otologicals Gram-negative bacteria Pathogenic bacteria Moxifloxacin Gemifloxacin Levofloxacin Quinolone Chemistry Organic chemistry Bacteria
6	Microsoft Word - Final_Gemifloxacin_8_2_2006_Background_Package.doc Add to Reading List Source URL: www.fda.gov Language: English - Date: 2006-09-11 08:16:53 Medicine Cyclopropanes Otologicals Drug safety Pefloxacin Gemifloxacin Ciprofloxacin Quinolone Ofloxacin Chemistry Piperazines Organic chemistry
7	Efficacy Review B.J. Ferguson, MD CC27 Need to Treat Sinusitis Add to Reading List Source URL: www.fda.gov Language: English - Date: 2006-11-13 13:21:29 Clinical research Design of experiments Epidemiology Piperazines Clinical trial Gemifloxacin Levofloxacin Chemistry Organic chemistry Cyclopropanes
8	DEPARTMENT Public Health Service- OF HEAL Add to Reading List Source URL: www.fda.gov Language: English - Date: 2004-11-05 15:37:46 Pharmaceutical sciences Term of patent in the United States United States patent law Gemifloxacin Food and Drug Administration Jon Dudas Chemistry Organic chemistry Cyclopropanes
9	DEPARTMENT & HUMAN OF HEAL Add to Reading List Source URL: www.fda.gov Language: English - Date: 2004-11-05 15:37:45 Pharmaceutical sciences Year of birth missing Term of patent in the United States United States patent law Gemifloxacin Food and Drug Administration Jon Dudas Chemistry Organic chemistry Cyclopropanes
10	PRESCRIBING INFORMATION FACTIVE® (gemifloxacin mesylate) Tablets Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2011-11-04 15:00:24 Gemifloxacin Pefloxacin Norfloxacin Quinolone Levofloxacin Ofloxacin Ciprofloxacin Ertapenem Community-acquired pneumonia Organic chemistry Chemistry Piperazines

UPDATE